Something has shifted in the last decade, and it is worth describing precisely, because the temptation to overstate it is enormous.
The shift is not that energy medicine has been validated. It has not. The shift is that questions in this category are increasingly being asked inside institutions with real methodological standards, real controls, and real peer review — which means they are being asked in a form that could produce a wrong answer. That is a change in the status of the questions, not in the status of the claims.
What is actually happening
In April 2026, researchers led by the Integrative Medicine Program at the University of Texas MD Anderson Cancer Center published a preclinical study in Cancer Medicine examining the effects of biofield therapy on pancreatic cancer models. The study ran four years, used sham, incubator, and animal colony control groups, and worked with three independent practitioners. It reported reduced cancer cell proliferation in vitro and a reduction of more than fifty percent in liver metastasis in repeated mouse experiments. The investigators’ own characterization was notably restrained: the work is preliminary, the mechanism is unknown, and it sets up human trials rather than substituting for them.
The same group published a double-blind case study in 2024 using simultaneous electrophysiological recording of the practitioner — EEG and heart-rate measures — alongside cellular outcomes, across sixty treatment and control sessions. Whatever one concludes about the results, the design is instructive: the investigators recognized that the interesting measurement problem runs in both directions.
On the funding side, the National Center for Complementary and Integrative Health, an NIH institute, maintains standing funding lines for mechanistic research into mind and body interventions, with “mechanisms and biomarkers of mind and body approaches” named among its stated scientific priorities. Its active funding opportunities call specifically for rigorous, well-powered human mechanistic studies supported by strong preliminary data — language indistinguishable from what any other NIH institute would use.
Alongside this, psychoneuroimmunology has become an ordinary biomedical discipline with journals, chairs, and a large mechanistic literature. Mind-body research — meditation, yoga, acupuncture, massage — now appears routinely in mainstream clinical journals and in the trial portfolios of major academic medical centers.
What this does not mean
It would be easy, and dishonest, to assemble the paragraphs above into an argument that the science is coming around. It is not, and the distinctions matter.
Preclinical is not clinical. Effects in cell culture and mouse models frequently fail to reproduce in humans — this is the ordinary attrition of biomedical research, not a special skepticism reserved for this field. A striking result in vitro is a reason to run a human trial, and nothing more.
One study is not a literature. A finding from a single group, however well controlled, awaits independent replication. This is doubly true for a result with no accepted mechanism, where the range of possible undetected confounds is wider than usual.
Funding a question is not answering it. NCCIH funds research into these approaches precisely because strong evidence about their safety and clinical benefit is often lacking. The existence of a funding line is evidence about institutional interest, not about outcomes.
And investigating a category is not endorsing every member of it. “Biofield therapy” and “mind-body intervention” are broad umbrellas containing practices with very different plausibility and very different evidence. Nothing about a study of one licenses a claim about another.
Why the shift matters anyway
With all of that subtracted, something real remains.
For most of the last century, these questions were not studied badly — they were largely not studied at all in serious settings, because associating with them carried a professional cost that few researchers could absorb. The consequence was that the empirical field was left to advocates, whose work was then criticized for being advocacy. That is a closed loop, and it produced exactly the evidence base you would predict.
What has changed is that the loop has opened slightly. When a top-ten cancer center runs a four-year controlled study and publishes it in a peer-reviewed oncology journal, the result is not the important part. The important part is that the question has become answerable in public: designed to be falsifiable, exposed to review, and available for someone else to fail to replicate.
This is the only route by which contested claims ever get resolved, in either direction. Most of them resolve toward no. That is fine. A field in which claims can resolve toward no is functioning correctly, and it is a strictly better situation than a field in which nothing resolves at all.
The connection to instrumentation
There is a reason this reopening is happening now, and it is not that attitudes softened. It is that the tools improved. Flow cytometry, cytokine assays, high-density EEG, continuous physiological monitoring, and cheap computation made it possible to ask mechanistic questions that previously could only be asked rhetorically.
That is the pattern this series keeps returning to. Categories do not move from fringe to legitimate because opinion shifts. They move because someone builds an instrument sensitive enough to produce data that opinion has to accommodate — and then the data, not the opinion, decides.
Regulatory note: Aurorus is a non-invasive electrophysiological measurement platform. It was granted FDA De Novo classification (DEN150004) as a Class I non-invasive electrophysiological measurement device. It is not cleared for diagnostic purposes. Nothing in this article claims that any therapy, modality, or practice diagnoses, treats, cures, or prevents any disease.
End · 4 min
Nancy Rizzo Prior to developing the science and technology for Aurorus, Nancy spent 13 years at Mayo Clinic Scottsdale as a board certified radiological therapeutic physicist and cochaired the Complementary and Alternative Medicine program. Nancy is board certified as a Radiological Therapeutic Physicist by the American Board of Radiology (DABR) and holds a Ph D. in Energy Medicine with an emphasis on Biophysics from Holos University.
Follow →